Coherus Oncology, Inc. (CHRS)
NASDAQ: CHRS · Real-Time Price · USD
1.500
+0.020 (1.35%)
At close: Jun 26, 2026, 4:00 PM EDT
1.490
-0.010 (-0.67%)
Pre-market: Jun 29, 2026, 4:04 AM EDT
Coherus Oncology Market Cap
Coherus Oncology has a market cap or net worth of $231.37 million as of June 29, 2026. Its market cap has increased by 147.99% in one year.
Market Cap
231.37M
Enterprise Value
118.70M
1-Year Change
147.99%
Ranking
Category
Stock Price
$1.50
Market Cap Chart
Since November 6, 2014, Coherus Oncology's market cap has decreased from $404.20M to $231.37M, a decrease of -42.76%. That is a compound annual growth rate of -4.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 231.40M | 34.85% |
| Dec 31, 2025 | 171.60M | 7.92% |
| Dec 31, 2024 | 159.00M | -57.12% |
| Dec 29, 2023 | 370.80M | -39.81% |
| Dec 30, 2022 | 616.00M | -49.73% |
| Dec 31, 2021 | 1.23B | -2.13% |
| Dec 31, 2020 | 1.25B | -0.83% |
| Dec 31, 2019 | 1.26B | 105.12% |
| Dec 31, 2018 | 615.60M | 20.73% |
| Dec 29, 2017 | 509.90M | -58.50% |
| Dec 30, 2016 | 1.23B | 37.60% |
| Dec 31, 2015 | 893.00M | 64.52% |
| Dec 31, 2014 | 542.80M | 34.29% |
| Nov 6, 2014 | 404.20M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fate Therapeutics | 244.77M |
| Anavex Life Sciences | 242.80M |
| Sol-Gel Technologies | 240.27M |
| Protara Therapeutics | 231.56M |
| Karyopharm Therapeutics | 231.39M |
| Atrium Therapeutics | 225.62M |
| Whitehawk Therapeutics | 223.74M |
| Q32 Bio | 223.32M |